Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania

NACompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

August 5, 2022

Study Completion Date

August 5, 2022

Conditions
Human Immunodeficiency VirusDiabetes Mellitus, Type 2Hypertension
Interventions
DIAGNOSTIC_TEST

Blood glucose and blood pressure testing

Diabetes will be assessed using a 6-question risk assessment on a 10-point scale (based on a field-tested and culturally adapted International Diabetes Federation formula on DM risk factors and symptoms) and a random blood glucose test with a portable finger stick glucose monitor. Those with either: (1) a risk score of 5 or more, or (2) a random blood glucose with a value greater than 140 mg/dl, will be asked to return after fasting for at least 8 hours to have a fasting glucose test taken. Blood pressure will be assessed using a portable battery operated automatic BP cuff. The BP test will include three values taken at least 5-minutes apart and the 3 will be averaged to determine the final value.

BEHAVIORAL

Diet and lifestyle counseling

All participants with elevated glucose or BP will receive personalized lifestyle counseling by trained counselors informed by lab results and that includes education on diabetes, hypertension, dietary assessment and recommendations, advice on physical activity, and the need to regularly monitor their glucose, BP, and adjust their diet, activity level, as needed. Personalized risk reduction plans will be negotiated with the client during their scheduled visits.

DRUG

DM/HTN medications as needed

Subjects will receive DM or HTN medications prescribed by the CTC clinician as needed.

Trial Locations (1)

Unknown

Muhimbili University of Health and Allied Sciences, Dar es Salaam

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Medical University of South Carolina

OTHER

NCT03098654 - Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania | Biotech Hunter | Biotech Hunter